The Utility of Two Rodent Species in Carcinogenic Risk Assessment of Pharmaceuticals in Europe

Author： van Oosterhout J.P.J.   van der Laan J.W.   de Waal E.J.   Olejniczak K.   Hilgenfeld M.   Schmidt V.   Bass R.  

Publisher： Academic Press

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.25, Iss.1, 1997-02, pp. : 6-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The in Vivo Rodent Test Systems for Assessment of Carcinogenic Potential

By van der Laan J.-W.   Spindler P.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 1, 2002-02 ,pp. : 122-125

Elsevier

Access to resources Recommend Favorite

Risk assessment for ecotoxicity of pharmaceuticals – an emerging issue

By Kar Supratik   Roy Kunal  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 235-274

Informa Healthcare

Access to resources Recommend Favorite

Procedures for Health Risk Assessment in Europe

By Seeley M.R.   Tonner-Navarro L.E.   Beck B.D.   deskin R.   Feron V.J.   Johanson G.   Bolt H.M.  

Regulatory Toxicology and Pharmacology, Vol. 34, Iss. 2, 2001-10 ,pp. : 153-169

Academic Press

Access to resources Recommend Favorite

Benefit–risk assessment: the use of clinical utility index

By Ouellet Daniele  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 289-300

Informa Healthcare

Access to resources Recommend Favorite

CARCINOGENIC EFFECTS OF BENZENE—A STATUS UPDATE AND RESEARCH NEEDS TO IMPROVE RISK ASSESSMENT: U.S. EPA PERSPECTIVE

By Sonawane Babasaheb   Bayliss David   Valcovic Lawrence   Chen Chao   Rodan Bruce   Farland William  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 5-6, 2000-11 ,pp. : 471-472

Taylor & Francis Ltd

Access to resources Recommend Favorite